A new study by Coralie Amadou, post doc in the Estrid group -- found that in the development adult-onset type 1 #diabetes, early-life factors might only play a small role.
👇
https://t.co/HxxyD8YIoQ
A comprehensive cohort study with @yuxia_wei as first author found that having a first-degree relative with #diabetes significantly increases the risk of developing #T1D as an adult & the risk is higher if the relative developed diabetes early.
👇🏽
https://t.co/6bAIP542Oz
A recent systematic review and meta-analysis by @AMLampousi shows that a moderate intake of #vitaminC, #vitaminE and β-carotene may reduce the risk of #T2D by mitigating #insulin resistance 🍊
👇🏽
https://t.co/ebWdbKOJer
@MarionBrunck @SofiaEJCarlsson Thank you @MarionBrunck! Yes, it is possible, although the associations were consistent in studies that adjusted for other dietary components. We suspect that supplements did not show any benefit because participants already had adequate intakes from diet.
Our new meta-analysis suggests that consuming moderate amounts of #vitamins C, E, and β-carotene may reduce the risk of type 2 #diabetes. But what about #supplements?
Read more in our latest publication in #AdvNutr! @SofiaEJCarlsson
https://t.co/uNbUQpiUqo
Fish oil /n-3 fatty acid intake during pregnancy unrelated to offspring risk of type 1 diabetes #T1D in pooled analysis of #MoBa and #DNBC. #Hedimed2020 open access in @DiabetologiaJnl today
https://t.co/c3LPzphepf
Up front & free to read in our Dec issue #editorspicks: The challenges of identifying and studying type 1 diabetes in adults https://t.co/yE7nqqjn7j
Every child should be given the best start in life.
Improving #newborn health requires more than obstetricians, neonatologists, and parents.
On #WorldPrematurityDay2023, our Editorial calls for more collaboration & investment: https://t.co/blXskls9mm
In honour of #WorldDiabetesDay, we'll share facts about #LADA and research findings from the group.
#LADA is a type of #diabetes with onset in adult years and is characterised by features of both #T1D and #T2D.
Learn more about the ESTRID study
👇🏽
https://t.co/qfVoLefI5e
This week marks the 59th Annual Meeting of #EASD in Hamburg. The ESTRID team is on site and excited to hear and share the newest #diabetes research.
#EASD2023#T1D#LADA#T2D
Our article on odd-chain fatty acids, GAD65 autoantibodies and adult-onset diabetes is now out and featured on the cover of Diabetologia! https://t.co/961X9GzgjQ
Our August cover shows an illustration of antibodies attached to a receptor on a cell. In this issue, Lampousi et al report that higher concentrations of the odd-chain fatty acid 17:0 are associated with lower risk of diabetes in people with GAD65 antibodies
Higher concentrations of the odd-chain fatty acid 17:0 are associated with a lower risk of progressing to diabetes in people with islet autoimmunity, according to findings from the EPIC-InterAct study. @AMLampousi@SofiaEJCarlsson@karolinskainst https://t.co/r2p976sUVx 🔓